Pfizer to Acquire Obesity-Drug Maker Metsera for $4.9 Bn
  • 22/09/2025
  • 0 comments

US pharmaceutical giant Pfizer will acquire Metsera, a maker of drugs for obesity and heart disease, for $4.9 billion, the companies said Monday. With the purchase Pfizer aims to expand its portfolio by entering the huge and growing market for medicines to treat obesity. "Obesity is a large and growing space with over 200 health conditions ...

Read more